Total investments 16
Average round size 
$17M
The average size of a deal this fund participated in
Portfolio companies 15
Rounds per year 1.78
Lead investments 0
Follow on index
0.06How often the fund supports its portfolio startups at next rounds
Key employees Soon
Beijing, Beijing, China Related Funds
Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Tigeryeah Capital:
Typical Co-investors
Tigeryeah Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Tigeryeah Capital:
There are no funds here. If we find new data, we will add it here.
Look at other 50 related and similar funds Collapse list ↓
| Fund Name | Location |
| BOD Tech Ventures | - |
| CHANEL | France, Ile-de-France, Neuilly-sur-seine |
| codecentric AG | Düsseldorf, Germany, Nordrhein-Westfalen |
| Cyrus Poonawalla Group | India, Maharashtra, Pune |
| Fairview Health Services | Minneapolis, Minnesota, United States |
| Flexible Funding | - |
| Gallo Digital | - |
| Gryphon Investments | Chesterfield, Missouri, United States |
| Heshi Jiye | China, Qingpu, Shanghai |
| Incepta Group | England, London, United Kingdom |
| Jordan Engineering | - |
| Lakewest Venture Partners | Chicago, Illinois, United States |
| LS Polaris Innovation Fund | - |
| NBGI Ventures | England, London, United Kingdom |
| Superangel | Estonia, Harjumaa, Tallinn |
| The Pearl Fund | - |
| Thorney Investment | Australia, Melbourne, Victoria |
| Unum Group | Chattanooga, Tennessee, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Weixin Medical | 10 Jul 2023 | Hangzhou, Zhejiang, China | |||
ChomiX Biotech | 15 May 2023 | Nanjing, Jiangsu, China | |||
Immorna | $13M | 27 Feb 2023 | Hangzhou, Zhejiang, China | ||
Epigenic Therapeutics | $20M | 07 Aug 2022 | Shanghai, Shanghai, China | ||
Tingsheng Technology | $15M | 03 Mar 2022 | Nanjing, Jiangsu, China | ||
Enze Kangtai | 11 Jan 2022 | Changping, Beijing, China | |||
Hesguard | $15M | 26 Dec 2021 | Suzhou, Jiangsu, China | ||
Hangzhou DAC Biotech Co., Ltd | $154M | 12 May 2021 | Shangcheng District, Zhejiang, China | ||
Novamab | $15M | 12 Mar 2021 | - |
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
To post a comment or write a complain, please sign in with LinkedIn
Review
- No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Do you represent Tigeryeah Capital?
Get access to manage this page
Found incorrect info? Let us know!
Total investments 16
Average round size 17M
Rounds per year 1.78
Peak activity year 2021
Lead investments 0
Follow on index 0.06
Group Appearance index 0.88
Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Weixin Medical | 10 Jul 2023 | Hangzhou, Zhejiang, China | |||
ChomiX Biotech | 15 May 2023 | Nanjing, Jiangsu, China | |||
Immorna | $13M | 27 Feb 2023 | Hangzhou, Zhejiang, China | ||
Epigenic Therapeutics | $20M | 07 Aug 2022 | Shanghai, Shanghai, China | ||
Tingsheng Technology | $15M | 03 Mar 2022 | Nanjing, Jiangsu, China | ||
Enze Kangtai | 11 Jan 2022 | Changping, Beijing, China | |||
Hesguard | $15M | 26 Dec 2021 | Suzhou, Jiangsu, China | ||
Hangzhou DAC Biotech Co., Ltd | $154M | 12 May 2021 | Shangcheng District, Zhejiang, China | ||
Novamab | $15M | 12 Mar 2021 | - |
